Hematology/Oncology
The Cancer Center at Penn Presbyterian, a member
of the University of Pennsylvania Cancer Network,
offers state-of-the-art treatment for all cancers
by our dedicated team of specialists with an
emphasis on investigational and novel agents.
The Developmental Therapeutics Program is a
program in the Division of Hematology/Oncology
dedicated to the identification, understanding
and testing of novel agents, or combination of
agents in the treatment or prevention of cancer.
This is accomplished through laboratory work,
pharmacokinetic and pharmacodynamic evaluation
and conducting clinical trials in patients with
cancer.
- Develop new treatments for patients with
cancer
- Understand how potential new treatments work
- Individualize dosing of chemotherapy
- Provide access to new and promising anti-cancer
agents
For more information, please visit our practice
profile.
See also:
|
